Cite
Inovio completes enrollment in phase 1 US trial of INO-4800 for COVID-19 DNA vaccine
MLA
“Inovio Completes Enrollment in Phase 1 US Trial of INO-4800 for COVID-19 DNA Vaccine.” PharmaBiz, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.622383488&authtype=sso&custid=ns315887.
APA
Inovio completes enrollment in phase 1 US trial of INO-4800 for COVID-19 DNA vaccine. (2020, April 30). PharmaBiz.
Chicago
PharmaBiz. 2020. “Inovio Completes Enrollment in Phase 1 US Trial of INO-4800 for COVID-19 DNA Vaccine,” April 30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.622383488&authtype=sso&custid=ns315887.